Several phenomena associated with tumor progression (inflammation, metabolic stress, or abnormal activation of signaling pathways, such as those controlled by TGF-β, Wnt, and Notch, among others) are known to trigger expression of EMT-TFs [23]. This evidence concerns the gene TGFB1 and neoplasm.